Cargando…
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis
BACKGROUND: Bacterial vaginosis (BV), a prevalent infection in women of reproductive age, is associated with increased risk of upper genital tract and sexually transmitted infections, and complications in pregnancy. Currently approved treatments include metronidazole, which requires once or twice da...
Autores principales: | Schwebke, Jane R., Marrazzo, Jeanne, Beelen, Andrew P., Sobel, Jack D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463027/ https://www.ncbi.nlm.nih.gov/pubmed/26222750 http://dx.doi.org/10.1097/OLQ.0000000000000300 |
Ejemplares similares
-
Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis: A Dose-Ranging Study
por: Chavoustie, Steven E., et al.
Publicado: (2015) -
Effect of metronidazole on vaginal microbiota associated with asymptomatic bacterial vaginosis
por: Ruiz-Perez, Daniel, et al.
Publicado: (2021) -
A comparison of the efficacy of metronidazole vaginal gel and Myrtus (Myrtus communis) extract combination and metronidazole vaginal gel alone in the treatment of recurrent bacterial vaginosis
por: Masoudi, Mansoureh, et al.
Publicado: (2017) -
Comparison between the efficacy of metronidazole vaginal gel and Berberis vulgaris (Berberis vulgaris) combined with metronidazole gel alone in the treatment of bacterial vaginosis
por: Masoudi, Mansoure, et al.
Publicado: (2016) -
Efficacy of Oral Metronidazole with Vaginal Clindamycin or Vaginal Probiotic for Bacterial Vaginosis: Randomised Placebo-Controlled Double-Blind Trial
por: Bradshaw, Catriona S., et al.
Publicado: (2012)